New research is underway that could help scientists combat the most lethal of cancers: pancreatic cancer. In a recent study, scientists demonstrated that bacteria in pancreatic tumors degrade a chemotherapy drug — Gemcitabine — most commonly used to treat patients who have pancreatic cancer.